Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Advanced Oncotherapy (AVO)

Price 1.925p on 28-03-2024 at 19:15:05
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell AVO Shares
Last Trade: -
Day's Volume: 0
Last Close: 1.925p
Open: 0.00p
ISIN: GB00BD6SX109
Day's Range 0.00p - 0.00p
52wk Range: 1.875p - 8.50p
Market Capitalisation: £10m
VWAP: 0.00p
Shares in Issue: 543m

Recent Trades History Advanced Oncotherapy (AVO)

Buy/Sell Volume Trade Prc Trade Type Trade Time

Share Price History for Advanced Oncotherapy

Time period:
to
Date Open High Low Close Volume

Share News for Advanced Oncotherapy

EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding

29th Feb 2024 18:52

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in February

2nd Feb 2024 14:06

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Regarding its recapitalisation plan, company works alongside investor towards initial tranche of funding, which it expects to be about USD15 million to be received this month. However, it adds that there can be no guarantee that this funding will be received, nor that it will be received on time. Further, Advanced Oncotherapy says it remains in advanced talks with a third-party investor regarding a short-term loan facility which would provide the company with additional short term bridge financing. Read More

IN BRIEF: Advanced Oncotherapy in advanced talks regarding loan

9th Jan 2024 14:06

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Continues to work on its recapitalisation plan with an unnamed third party investor. Says discussions are at an advanced stage but has not entered into any binding agreements with the investor, nor received any funds. This comes after it signed a non-binding term sheet with the investor in October. The investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. The firm currently owes GBP28 million to trade and other unsecured creditors and GBP41 million of financial debt. Read More

IN BRIEF: Advanced Oncotherapy in talks over possible cash injection

23rd Oct 2023 18:51

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Updates on financing discussions and current financial position. Signs non-binding term sheet with a third-party investor. Investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. Read More

IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue

3rd Oct 2023 18:29

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - On Friday, says it is not in a position to publish its accounts for the year ended December 31, 2022, and the unaudited interim results for the six months ended June 30, together with the 2022 annual report. Explains the 2023 interim results are contingent on the finalisation and publication of the 2022 annual report. Read More

FTSE 100 Latest
Value7,952.62
Change20.64

Login to your account

Forgot Password?

Not Registered